Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01462305 · ClinicalTrials.gov registry record · NA
30-Minute Light Exposure for the Treatment of Seasonal Affective Disorder
A NA study of Seasonal Affective Disorder, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 4
- Study locations
NCT01462305 is a NA study of Seasonal Affective Disorder that has completed, run by Philips Respironics. The registered enrollment target is 35 participants, below the 72-participant average among 3 other Seasonal Affective Disorder trials with a reported enrollment target (51% lower). The trial reports 4 study locations across 3 states.
The verdict
NCT01462305, a NA study of Seasonal Affective Disorder, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 4
- Study locations
Study Summary
The primary objective of this study is to evaluate the effect of light therapy using a narrow 467nm light compared to a 580nm light in subjects with Seasonal Affective Disorder (SAD). It is hypothesized that the 467nm light will improve the symptoms of SAD better than the 580nm light.
Conditions Studied
Interventions
- DEVICE Control
- DEVICE goLITE
Study Locations (4)
Massachusetts
- McLean Hospital - Belmont
- Brigham & Women's Hospital - Boston
Minnesota
- University of Minnesota - Minneapolis
Ohio
- Community Research Management Associates - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2012-01-06 |
| Est. Completion | 2012-04-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01462305
The ClinicalTrials.gov registry entry for NCT01462305 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 72-participant average among 3 other Seasonal Affective Disorder trials with a reported enrollment target (51% lower). The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Seasonal Affective Disorder appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.
NCT01462305 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, Minnesota, Ohio.
Frequently Asked Questions
What is clinical trial NCT01462305 about?
NCT01462305 is a clinical study titled "30-Minute Light Exposure for the Treatment of Seasonal Affective Disorder". The primary objective of this study is to evaluate the effect of light therapy using a narrow 467nm light compared to a 580nm light in subjects with Seasonal Affective Disorder (SAD). It is hypothesized that the 467nm light will improve the symptoms of SAD better than the 580nm light.
What is the current status of trial NCT01462305?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2012-01-06. Estimated completion is 2012-04-02.
What conditions does trial NCT01462305 study?
This clinical trial studies the following conditions: Seasonal Affective Disorder.
What interventions are being tested in trial NCT01462305?
The interventions under investigation include: Control (DEVICE), goLITE (DEVICE).
Who is sponsoring clinical trial NCT01462305?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01462305 being conducted?
This trial has 4 study locations across Massachusetts, Minnesota, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Seasonal Affective Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effects of Season on Melatonin Secretion in Healthy Men and Women and Patients With Seasonal Affective Disorder
COMPLETED
-
Study of Genes in Relation to Seasonal Affective Disorder and Major Depressive Disorder
COMPLETED
-
Clinical Trial of Propranolol for Seasonal Affective Disorder
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.